Evidence map›Paper›PMID 40097830›Full record

ArticlePediatric research2025

Association between early-phase opioid use and outcomes in extremely preterm infants: A nationwide study.

Hiroki Kitaoka, Takaaki Konishi, Yoshihiko Shitara, Atsushi Ito, Kohei Kashima, Yuya Kimura, Hiroki Matsui, Motohiro Kato, Naoto Takahashi, Hideo Yasunaga

Abstract read
In one paragraph

Article in Pediatric research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Opioid exposure on the preterm brain: qualitative and quantitative MRI analysis.Intensive care medicine. Paediatric and neonatal · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hiroki KitaokaDepartment of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan. kitaokahir@m.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-0958-5028
Takaaki KonishiDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Yoshihiko ShitaraDepartment of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Atsushi ItoDepartment of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Kohei KashimaDepartment of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Yuya KimuraDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Hiroki MatsuiDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Motohiro KatoDepartment of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Naoto TakahashiDepartment of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Hideo YasunagaDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOpioids are often administered for extremely preterm infants to prevent morbidities (e.g., intraventricular hemorrhage); however, their short-term outcome remains unclear. We aimed to assess the association between early-phase opioid use and in-hospital outcomes in extremely preterm infants.

methodsThis retrospective nationwide cohort study analyzed data from the Diagnosis Procedure Combination database in Japan. A total of 18,794 extremely preterm infants hospitalized between July 2010 and March 2021 were included. The patients were divided into those who received early-phase opioids (n = 4806) and those who did not (n = 13,988). We performed a 1:2 propensity score-matched analysis adjusting for patient backgrounds.

resultsIn-hospital mortality, intraventricular hemorrhage, and periventricular leukomalacia occurred in 8.5%, 13%, and 2.1% of the patients, respectively. The incidences of in-hospital mortality (12% vs. 12%) and intraventricular hemorrhage (14% vs. 15%) did not differ between the two groups after 1:2 propensity score matching. The patients who received early-phase opioids had a lower incidence of periventricular leukomalacia than those who did not (1.7% vs. 2.2%). However, bronchopulmonary dysplasia occurrence (65% vs. 58%), home assistive technology use (19% vs. 15%), and length of hospital stay (125 vs. 122 days) were increased for patients who received early-phase opioids.

conclusionIn this large retrospective study, early-phase opioid use in extremely preterm infants was not associated with increased mortality or intraventricular hemorrhage. Periventricular leukomalacia slightly decreased. IMPACT: This large retrospective nationwide study of 13,988 extremely preterm infants revealed that using early-phase opioids was not significantly associated with in-hospital mortality or intraventricular hemorrhage but was significantly associated with a decrease in periventricular leukomalacia. Early-phase opioids may not increase mortality or intraventricular hemorrhage, in contrast to the results of previous studies. Thus, these results could help clinicians select opioids as sedative agents for extremely preterm infants.

Indexed as

Analgesics, OpioidInfant, Extremely PrematureFemaleHospital MortalityHumansIncidenceInfantInfant, NewbornJapanLeukomalacia, PeriventricularMalePropensity ScoreRetrospective StudiesAnalgesics, Opioid

Identifiers

PMID40097830
PMCPMC12602305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.